Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2018 Filed Feb 22, 2019 21:01 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-19-000077 · primary_doc.xml · derivative · entry 19 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F19 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · derivative.exercise_date: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Feb 22, 2019 21:57 UTC |
QUIST SCOTT MDirector · Chrmn of Board; Pres; CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 73,500 | $5.77 Strike: $5.77 | $424,095.00 |
DisclosureSEC source: 0001096906-19-000078 · primary_doc.xml · derivative · entry 7 QUIST SCOTT M · CIK 0001268844 · Director · Chrmn of Board; Pres; CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,500 Underlying: Class A Common Stock · 73,500 shares Expires 2023-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · derivative.exercise_date: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Feb 22, 2019 18:53 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.24 Strike: $5.24 | $5,502.00 |
DisclosureSEC source: 0001096906-19-000076 · primary_doc.xml · derivative · entry 20 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F20 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F20 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F20 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F20 · derivative.exercise_date: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F20 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F20 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Feb 22, 2019 18:53 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-19-000076 · primary_doc.xml · derivative · entry 19 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F19 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · derivative.exercise_date: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F19 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Feb 22, 2019 17:51 UTC |
Quist Adam GeorgeVP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,000 | $5.24 Strike: $5.24 | $110,040.00 |
DisclosureSEC source: 0001096906-19-000075 · primary_doc.xml · derivative · entry 6 Quist Adam George · CIK 0001740330 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Class C Common Stock · 21,000 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · price: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.exercise_date: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Feb 25, 2019 16:47 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,250 | $5.24 Strike: $5.24 | $137,550.00 |
DisclosureSEC source: 0001096906-19-000079 · primary_doc.xml · derivative · entry 8 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Class C Common Stock · 26,250 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · derivative.exercise_date: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class C Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Apr 19, 2019 23:02 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.25 Strike: $5.25 | $5,512.50 |
DisclosureSEC source: 0001096906-19-000148 · primary_doc.xml · derivative · entry 13 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F10 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F10 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F10 · derivative.exercise_date: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F10 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Apr 19, 2019 23:02 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-19-000148 · primary_doc.xml · derivative · entry 12 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · derivative.exercise_date: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed May 22, 2019 19:07 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,250 | $5.24 Strike: $5.24 | $27,510.00 |
DisclosureSEC source: 0001096906-19-000216 · primary_doc.xml · derivative · entry 8 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.exercise_date: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. This option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Jul 8, 2019 20:35 UTC |
QUIST SCOTT MDirector · Chrmn of Board; Pres; CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 73,500 | $5.77 Strike: $5.77 | $424,095.00 |
DisclosureSEC source: 0001096906-19-000256 · primary_doc.xml · derivative · entry 7 QUIST SCOTT M · CIK 0001268844 · Director · Chrmn of Board; Pres; CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,500 Underlying: Class A Common Stock · 73,500 shares Expires 2023-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.exercise_date: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Aug 1, 2019 17:36 UTC Amendment |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 73,500 | $5.77 Strike: $5.77 | $424,095.00 |
DisclosureSEC source: 0001096906-19-000271 · primary_doc.xml · derivative · entry 9 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,500 Underlying: Class A Common Stock · 73,500 shares Expires 2023-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · derivative.exercise_date: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F9 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Sep 27, 2019 17:39 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.25 Strike: $5.25 | $5,512.50 |
DisclosureSEC source: 0001096906-19-000338 · primary_doc.xml · derivative · entry 9 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · derivative.exercise_date: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Sep 27, 2019 17:39 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-19-000338 · primary_doc.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.exercise_date: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Nov 22, 2019 17:46 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.25 Strike: $5.25 | $5,512.50 |
DisclosureSEC source: 0001096906-19-000396 · primary_doc.xml · derivative · entry 9 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · derivative.exercise_date: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Nov 22, 2019 17:46 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-19-000396 · primary_doc.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.exercise_date: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. The option vests in four equal quarterly installments of Class A Common Stock, beginning on February 28, 2019, until such shares are fully vested. Read SEC document |
| November 30, 2018 Filed Dec 13, 2019 16:44 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.25 Strike: $5.25 | $5,512.50 |
DisclosureSEC source: 0001096906-19-000413 · primary_doc.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 13, 2019 16:44 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-19-000413 · primary_doc.xml · derivative · entry 7 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 17, 2019 18:42 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.24 Strike: $5.24 | $5,502.00 |
DisclosureSEC source: 0001096906-19-000423 · primary_doc.xml · derivative · entry 19 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F19 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. F19 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. F19 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. F19 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. F19 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 17, 2019 18:42 UTC |
Hunter Robert GailDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-19-000423 · primary_doc.xml · derivative · entry 18 Hunter Robert Gail · CIK 0001298091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F18 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. F18 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. F18 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. F18 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. F18 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock option paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 17, 2019 20:19 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.25 Strike: $5.25 | $5,512.50 |
DisclosureSEC source: 0001096906-19-000427 · primary_doc.xml · derivative · entry 21 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F19 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F19 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F19 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F19 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F19 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 17, 2019 20:19 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-19-000427 · primary_doc.xml · derivative · entry 20 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F18 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F18 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F18 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F18 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F18 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 17, 2019 21:37 UTC |
Sill Garrett S.CFO; Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,000 | $5.24 Strike: $5.24 | $110,040.00 |
DisclosureSEC source: 0001096906-19-000429 · primary_doc.xml · derivative · entry 7 Sill Garrett S. · CIK 0001568673 · CFO; Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Class C Common Stock · 21,000 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · price: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · balance_after: This option was granted on November 30, 2018 as an option for either 20,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 20,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 17, 2019 17:44 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.24 Strike: $5.24 | $5,502.00 |
DisclosureSEC source: 0001096906-19-000420 · primary_doc.xml · derivative · entry 12 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F12 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F12 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F12 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F12 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F12 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 17, 2019 17:44 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.24 Strike: $5.24 | $27,510.00 |
DisclosureSEC source: 0001096906-19-000420 · primary_doc.xml · derivative · entry 11 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 17, 2019 17:04 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.24 Strike: $5.24 | $5,502.00 |
DisclosureSEC source: 0001096906-19-000417 · primary_doc.xml · derivative · entry 11 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 17, 2019 17:04 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.24 Strike: $5.24 | $27,510.00 |
DisclosureSEC source: 0001096906-19-000417 · primary_doc.xml · derivative · entry 10 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F10 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F10 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F10 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 19, 2019 18:40 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,250 | $5.24 Strike: $5.24 | $137,550.00 |
DisclosureSEC source: 0001096906-19-000433 · primary_doc.xml · derivative · entry 7 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Class C Common Stock · 26,250 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 19, 2019 18:01 UTC |
Stephens Jeffrey RussellSr. Gen Council; Corp Sec
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,875 | $5.24 Strike: $5.24 | $41,265.00 |
DisclosureSEC source: 0001096906-19-000432 · primary_doc.xml · derivative · entry 8 Stephens Jeffrey Russell · CIK 0001488171 · Sr. Gen Council; Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,875 Underlying: Class A Common Stock · 7,875 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a stock dividend paid on February 1, 2019. F8 · shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a stock dividend paid on February 1, 2019. F8 · price: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a stock dividend paid on February 1, 2019. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a stock dividend paid on February 1, 2019. F8 · balance_after: This option was granted on November 30, 2018 as an option for 7,500 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilutions provisions of the 2013 Stock Option Plan to reflect a stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 20, 2019 18:14 UTC |
Quist S. AndrewDirector · VP & General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,250 | $5.24 Strike: $5.24 | $137,550.00 |
DisclosureSEC source: 0001096906-19-000436 · primary_doc.xml · derivative · entry 10 Quist S. Andrew · CIK 0001588309 · Director · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Class C Common Stock · 26,250 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F9 · shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F9 · price: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F9 · balance_after: This option was granted on November 30, 2018 as an option for either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 20, 2019 16:35 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,250 | $5.24 Strike: $5.24 | $27,510.00 |
DisclosureSEC source: 0001096906-19-000434 · primary_doc.xml · derivative · entry 7 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F6 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F6 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F6 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F6 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F6 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 26, 2019 17:53 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.25 Strike: $5.25 | $5,512.50 |
DisclosureSEC source: 0001096906-19-000438 · primary_doc.xml · derivative · entry 9 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Dec 26, 2019 17:53 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-19-000438 · primary_doc.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Jan 6, 2020 23:27 UTC Amendment |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 73,500 | $5.77 Strike: $5.77 | $424,095.00 |
DisclosureSEC source: 0001096906-20-000004 · primary_doc.xml · derivative · entry 8 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,500 Underlying: Class A Common Stock · 73,500 shares Expires 2023-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Jan 6, 2020 22:47 UTC |
QUIST SCOTT MDirector · Chairman of the Board,Pres,CEO · 10% owner
|
GrantEmployee Stock Option (right to buy) · Derivative | 73,500 | $5.77 Strike: $5.77 | $424,095.00 |
DisclosureSEC source: 0001096906-20-000003 · primary_doc.xml · derivative · entry 8 QUIST SCOTT M · CIK 0001268844 · Director · Chairman of the Board,Pres,CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,500 Underlying: Class A Common Stock · 73,500 shares Expires 2023-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · price: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F8 · balance_after: This option was granted on November 30, 2018 as an option for 70,000 shares of Class A Common Stock at an exercise price of $6.07 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Jan 6, 2020 18:38 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,050 | $5.25 Strike: $5.25 | $5,512.50 |
DisclosureSEC source: 0001096906-20-000002 · primary_doc.xml · derivative · entry 19 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Class A Common Stock · 1,050 shares Expires 2028-11-30 F17 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F17 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F17 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F17 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F17 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Jan 6, 2020 18:38 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,250 | $5.25 Strike: $5.25 | $27,562.50 |
DisclosureSEC source: 0001096906-20-000002 · primary_doc.xml · derivative · entry 18 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F16 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F16 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F16 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F16 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F16 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Jan 10, 2020 18:47 UTC |
Christie Q. OverbaughSr. VP Life Ins. Inter. Op.
|
GrantEmployee Stock Option (right to buy) · Derivative | 5,250 | $5.24 Strike: $5.24 | $27,510.00 |
DisclosureSEC source: 0001096906-20-000009 · primary_doc.xml · derivative · entry 6 Christie Q. Overbaugh · CIK 0001320385 · Sr. VP Life Ins. Inter. Op. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Class A Common Stock · 5,250 shares Expires 2028-11-30 F5 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F5 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F5 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F5 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F5 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Jan 15, 2020 20:19 UTC |
Overbaugh Jason G.Director · VP & Nat Mrk Dir of Life Ins
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,250 | $5.24 Strike: $5.24 | $137,550.00 |
DisclosureSEC source: 0001096906-20-000010 · primary_doc.xml · derivative · entry 12 Overbaugh Jason G. · CIK 0001588310 · Director · VP & Nat Mrk Dir of Life Ins 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Underlying: Class C Common Stock · 26,250 shares Expires 2028-11-30 F7 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · price: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. F7 · balance_after: This option was granted on November 30, 2018 as an option to purchase either 25,000 shares of Class A Common Stock at an exercise price of $5.52 per share or 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, or any combination thereof. This option reflects the reporting person's election to have an option for 25,000 shares of Class C Common Stock at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution rights of the 2013 Stock Option Plan to reflect a 5% stock dividend paid on February 1, 2019. Read SEC document |
| November 30, 2018 Filed Feb 12, 2020 16:40 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.98 Strike: $4.98 | $5,492.94 |
DisclosureSEC source: 0001096906-20-000067 · primary_doc.xml · derivative · entry 13 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F13 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F13 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F13 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F13 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F13 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Feb 12, 2020 16:40 UTC |
FULLER GILBERT ADirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001096906-20-000067 · primary_doc.xml · derivative · entry 12 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F12 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F12 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Feb 12, 2020 18:18 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.98 Strike: $4.98 | $5,492.94 |
DisclosureSEC source: 0001096906-20-000072 · primary_doc.xml · derivative · entry 11 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Feb 12, 2020 18:18 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001096906-20-000072 · primary_doc.xml · derivative · entry 10 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Feb 12, 2020 20:23 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001096906-20-000075 · primary_doc.xml · derivative · entry 16 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F16 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F16 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F16 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F16 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F16 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Feb 12, 2020 20:23 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001096906-20-000075 · primary_doc.xml · derivative · entry 15 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Feb 12, 2020 17:33 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001096906-20-000068 · primary_doc.xml · derivative · entry 9 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F9 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · price: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F9 · balance_after: This option was granted on November 30, 2018 as an option to purchase 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed Feb 12, 2020 17:33 UTC |
Wilbur Norman GDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.99 Strike: $4.99 | $27,509.87 |
DisclosureSEC source: 0001096906-20-000068 · primary_doc.xml · derivative · entry 8 Wilbur Norman G · CIK 0001298096 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F8 · derivative.exercise_price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · price: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F8 · balance_after: This option was granted on November 30, 2018 as an option to purchase 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 1, 2020 21:41 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.99 Strike: $4.99 | $5,503.97 |
DisclosureSEC source: 0001445866-20-000523 · primary_doc.xml · derivative · entry 19 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F15 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F15 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 1, 2020 21:41 UTC |
MOODY H. CRAIGDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000523 · primary_doc.xml · derivative · entry 18 MOODY H. CRAIG · CIK 0001298129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F14 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. F14 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 7, 2020 22:53 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,103 | $4.98 Strike: $4.98 | $5,492.94 |
DisclosureSEC source: 0001445866-20-000573 · form4.xml · derivative · entry 11 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103 Underlying: Class A Common Stock · 1,103 shares Expires 2028-11-30 F11 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · price: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F11 · balance_after: This option was granted on November 30, 2018 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
| November 30, 2018 Filed May 7, 2020 22:53 UTC |
Cook John LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 5,513 | $4.98 Strike: $4.98 | $27,454.74 |
DisclosureSEC source: 0001445866-20-000573 · form4.xml · derivative · entry 10 Cook John L · CIK 0001593993 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,513 Underlying: Class A Common Stock · 5,513 shares Expires 2028-11-30 F10 · derivative.exercise_price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · price: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · derivative.underlying_shares: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. F10 · balance_after: This option was granted on November 30, 2018 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividends paid on February 1, 2019 and February 7, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.